Tumeh et al. have shown that pre-existing tumor-infiltrating CD8+ T cell clones expand after PD-1 checkpoint blockade and this underlies the positive response of advanced melanoma patients to therapy (10). The gene discussed is CD8A; the disease is melanoma.